Although the "Wei Zexi" incident has caused the reputation of the private hospitals in Putian to plummet, it does not obliterate its position in China's medical care and the road to the wealth of the Putian capitalists. In particular, Zhan, Chen, Lin, and Huang, who are in a large-scale business and operate in a group.
In 2002, Lin Yuming, the second generation of the Putian Department, which sells medical equipment in Shanxi, observed that the public hospitals did not pay much attention to obstetrics and gynaecology because of the long-term docking of medical institutions. The most obvious is the shortage of beds, so that the mothers had to live. Produced in the corridor. "If you can solve the bed problem and use the specialist technology to provide more humanized services, such a hospital should not lack the market."
Therefore, Lin Yuming took his Bosheng Medical Group to establish the first female specialized hospital in China, Taiyang Modern Maternity Hospital, in Taiyuan City, and pioneered the operation mode of Chinese women's specialist medical services. Since then, “Modern†brand has sprung up in China, and has built a number of chain hospitals in large and medium-sized cities such as Chongqing, Wuhan, Changsha, Guangzhou, Tianjin and Guiyang.
The successful operation of “Modern†brand allowed Lin Yuming to taste the “sweetness†of private specialty hospitals. As the saying goes, "No one will be too much money." Immediately afterwards, Lin Yuming copied the "modern" management model and operational process, and created chain brands such as "Huimei" and "Suiren" in several provinces.
Lin Yuming’s move directly led Bosen Medical Group to own a group of more than 20 chain hospitals. Became the "Mary" brand of Zhan Guotuan, Lin Zhizhong's "Bo Ai" brand, Chen Jinxiu's "Hua Xia" brand, Huang Defeng's "Tian Lun" brand, and another Putian medical group.
In July 2015, Lin Yuming split the “Hemei†brand into Hemei Medical (01509) and went to Hong Kong for listing. The global sales of 210.81 million shares raised funds of HK$1,591.6 million. On the first day of listing, although Morgan Stanley increased its holdings by approximately 165 million Hong Kong dollars, it did not drive its share price to rise, closing at HK$6.81, which was lower than the offer price of HK$7.55.
Like all new shares, the United States and the United States have been in the “high and low time†inspection period. In the second quarter of 2016, the “Wei Zexi†incident made the Putian Department Hospital a target, and Hemei Medical naturally failed to escape the crisis. Zhitong Finance observed that during the 77 trading days from April 26 to August 26, 2016, the stock range fell by nearly 72 points, including 8.25% on June 17, and 15.02% on the 20th. On August 24, it fell 8.3%.
After the "Wei Zexi" incident, the stock price of Hemei Medical finally improved in early November 2016, but it was not good for a long time. On November 17, the stock once again fell into the quagmire of "7 days of falling". At this point, Hemei Medical's share price has entered a long period of weakness...
Metallurgical Microscope
Metallurgical Microscope,Laboratory Microscope,Upright Metallurgical Microscope,Upright Laboratory Microscope
NINGBO VANCO INSTRUMENT CO.,LTD , https://www.vancoscope.com